Curtis Triplitt Selected Research

Curtis Triplitt Research Topics

Disease

42	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2006
14	Insulin Resistance 01/2022 - 12/2002
5	Hypoglycemia (Reactive Hypoglycemia) 03/2017 - 06/2010
4	Hyperglycemia 12/2015 - 12/2007
3	Weight Loss (Weight Reduction) 01/2020 - 05/2006
2	Disease Progression 10/2023 - 12/2007
2	Glycosuria 07/2023 - 01/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 06/2010
2	Inflammation (Inflammations) 08/2022 - 01/2008
2	Body Weight (Weight, Body) 01/2020 - 01/2015
2	Weight Gain 03/2017 - 05/2010
2	Diabetes Mellitus 01/2007 - 01/2006
1	Glucose Intolerance 12/2023
1	Albuminuria 10/2023
1	Chronic Renal Insufficiency 10/2023
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Heart Failure 08/2021
1	Arteritis 08/2014
1	Atherosclerosis 08/2014
1	Infections 01/2014
1	Hyperemia 01/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2007
1	Nausea 01/2006

Drug/Important Bio-Agent (IBA)

24	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 12/2002
18	Insulin (Novolin)FDA Link 07/2023 - 12/2002
15	Exenatide (Byetta)FDA Link 07/2023 - 01/2006
9	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2006
8	Pioglitazone (Actos)FDA Link 01/2022 - 01/2008
6	Glucagon (Glukagon)FDA Link 07/2023 - 05/2006
5	empagliflozinIBA 12/2023 - 01/2017
5	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2023 - 01/2014
5	IncretinsIBA 12/2007 - 01/2006
4	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2023 - 01/2006
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021 - 03/2006
4	Liraglutide FDA Link 10/2020 - 12/2015
4	CanagliflozinIBA 10/2020 - 01/2015
3	dapagliflozinIBA 07/2023 - 10/2020
3	Hypoglycemic Agents (Hypoglycemics)IBA 08/2021 - 03/2006
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2015 - 01/2006
2	Bromocriptine (Parlodel)FDA LinkGeneric 08/2022 - 10/2018
2	Glucagon-Like Peptide-1 ReceptorIBA 08/2022 - 05/2006
2	C-PeptideIBA 01/2022 - 01/2018
2	Glipizide (Glucotrol)FDA LinkGeneric 01/2022 - 01/2021
2	SodiumIBA 01/2021 - 01/2018
2	Sodium-Glucose Transport ProteinsIBA 10/2020 - 01/2015
2	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2020 - 03/2006
2	Rosiglitazone (Avandia)FDA Link 05/2010 - 11/2006
1	Peptides (Polypeptides)IBA 01/2024
1	apararenoneIBA 10/2023
1	esaxerenoneIBA 10/2023
1	Mineralocorticoid Receptor AntagonistsIBA 10/2023
1	ProlactinIBA 08/2022
1	3-nitrotyrosineIBA 08/2022
1	C-Reactive ProteinIBA 08/2022
1	Dopamine (Intropin)FDA LinkGeneric 08/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 08/2022
1	NormetanephrineIBA 08/2022
1	SympatholyticsIBA 08/2022
1	Thiobarbituric Acid Reactive SubstancesIBA 08/2022
1	Dopamine Agonists (Dopamine Agonist)IBA 08/2022
1	L-SelectinIBA 08/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Protons (Proton)IBA 01/2022
1	fibroblast growth factor 21IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	CarbohydratesIBA 01/2022
1	saxagliptin FDA Link 10/2020
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	KetonesIBA 01/2017
1	rGLP-1 proteinIBA 12/2015
1	Insulin SecretagoguesIBA 12/2015
1	dulaglutideIBA 12/2015
1	MineralsIBA 01/2014
1	PhlorhizinIBA 01/2014
1	Sitagliptin Phosphate (Januvia)FDA Link 09/2013
1	alogliptinIBA 09/2010
1	ThiazolidinedionesIBA 08/2010
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2008
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2008
1	Ramipril (Altace)FDA LinkGeneric 01/2008
1	Hemoglobins (Hemoglobin)IBA 12/2007
1	Insulin Glargine (Lantus)FDA Link 11/2006
1	Islet Amyloid PolypeptideIBA 01/2006
1	Proteins (Proteins, Gene)FDA Link 01/2006

Therapy/Procedure

22	Therapeutics 01/2024 - 01/2006
8	Glycemic Control 07/2023 - 01/2006
2	Injections 12/2015 - 01/2008
1	Denervation 01/2020
1	Aftercare (After-Treatment) 01/2017
1	Pancreatectomy 01/2014